WO2008077172A3 - Use of polymers - Google Patents

Use of polymers Download PDF

Info

Publication number
WO2008077172A3
WO2008077172A3 PCT/AT2007/000585 AT2007000585W WO2008077172A3 WO 2008077172 A3 WO2008077172 A3 WO 2008077172A3 AT 2007000585 W AT2007000585 W AT 2007000585W WO 2008077172 A3 WO2008077172 A3 WO 2008077172A3
Authority
WO
WIPO (PCT)
Prior art keywords
polymers
polymer
thiol
polysaccharide
implant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/AT2007/000585
Other languages
French (fr)
Other versions
WO2008077172A2 (en
Inventor
Margit Hornof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Croma Pharma GmbH
Original Assignee
Croma Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41514873&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2008077172(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to EP07855366A priority Critical patent/EP2107913B1/en
Priority to BRPI0722061A priority patent/BRPI0722061B8/en
Priority to ES07855366T priority patent/ES2391862T3/en
Priority to CN200780047621.3A priority patent/CN101622017B/en
Priority to JP2009541680A priority patent/JP5513893B2/en
Priority to CA2673323A priority patent/CA2673323C/en
Priority to AU2007336692A priority patent/AU2007336692B2/en
Application filed by Croma Pharma GmbH filed Critical Croma Pharma GmbH
Priority to DK07855366.6T priority patent/DK2107913T3/en
Priority to US12/520,820 priority patent/US9597277B2/en
Priority to PL07855366T priority patent/PL2107913T3/en
Priority to AT07855366T priority patent/ATE545436T1/en
Priority to SI200730903T priority patent/SI2107913T1/en
Publication of WO2008077172A2 publication Critical patent/WO2008077172A2/en
Publication of WO2008077172A3 publication Critical patent/WO2008077172A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Graft Or Block Polymers (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

The present invention relates to the use of a thiol-group-containing polymer for preparing an implant for tissue augmentation, wherein the basis polymer is a polysaccharide.
PCT/AT2007/000585 2006-12-22 2007-12-21 Use of polymers Ceased WO2008077172A2 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SI200730903T SI2107913T1 (en) 2006-12-22 2007-12-21 Use of thiolated polysaccharides for tissue augmentation
DK07855366.6T DK2107913T3 (en) 2006-12-22 2007-12-21 Use of thiolated polysaccharides for tissue building
ES07855366T ES2391862T3 (en) 2006-12-22 2007-12-21 Use of thiolated polysaccharides for tissue augmentation
CN200780047621.3A CN101622017B (en) 2006-12-22 2007-12-21 The purposes of polymer
JP2009541680A JP5513893B2 (en) 2006-12-22 2007-12-21 Tissue augmentation implant
CA2673323A CA2673323C (en) 2006-12-22 2007-12-21 Use of thiol-containing polysaccharides as implants for tissue augmentation
AU2007336692A AU2007336692B2 (en) 2006-12-22 2007-12-21 Use of polymers
EP07855366A EP2107913B1 (en) 2006-12-22 2007-12-21 Use of thiolated polysaccharides for tissue augmentation
PL07855366T PL2107913T3 (en) 2006-12-22 2007-12-21 Use of thiolated polysaccharides for tissue augmentation
BRPI0722061A BRPI0722061B8 (en) 2006-12-22 2007-12-21 use of a polymer containing thiol group and implant
US12/520,820 US9597277B2 (en) 2006-12-22 2007-12-21 Use of polymers
AT07855366T ATE545436T1 (en) 2006-12-22 2007-12-21 USE OF THIOLATED POLYSACCHARIDES FOR TISSUE BUILDING

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87153406P 2006-12-22 2006-12-22
AT21362006 2006-12-22
US60/871,534 2006-12-22
ATA2136/2006 2006-12-22

Publications (2)

Publication Number Publication Date
WO2008077172A2 WO2008077172A2 (en) 2008-07-03
WO2008077172A3 true WO2008077172A3 (en) 2009-05-14

Family

ID=41514873

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AT2007/000585 Ceased WO2008077172A2 (en) 2006-12-22 2007-12-21 Use of polymers

Country Status (16)

Country Link
US (1) US9597277B2 (en)
EP (1) EP2107913B1 (en)
JP (1) JP5513893B2 (en)
CN (1) CN101622017B (en)
AT (1) ATE545436T1 (en)
AU (1) AU2007336692B2 (en)
BR (1) BRPI0722061B8 (en)
CA (1) CA2673323C (en)
CY (1) CY1112623T1 (en)
DK (1) DK2107913T3 (en)
ES (1) ES2391862T3 (en)
PL (1) PL2107913T3 (en)
PT (1) PT2107913E (en)
RU (1) RU2432181C2 (en)
SI (1) SI2107913T1 (en)
WO (1) WO2008077172A2 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3287804B2 (en) 1998-07-23 2002-06-04 株式会社ミツバ Wiper installation structure
FR2861734B1 (en) 2003-04-10 2006-04-14 Corneal Ind CROSSLINKING OF LOW AND HIGH MOLECULAR MASS POLYSACCHARIDES; PREPARATION OF INJECTABLE SINGLE PHASE HYDROGELS; POLYSACCHARIDES AND HYDROGELS OBTAINED
PT2818184T (en) 2007-11-16 2019-01-28 Aclaris Therapeutics Inc Compositions and methods for treating purpura
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
CA2735173C (en) 2008-09-02 2017-01-10 Tautona Group Lp Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
CN101721349B (en) 2008-10-16 2011-07-20 常州百瑞吉生物医药有限公司 Injectable in-situ crosslinking aquogel and preparation method and application thereof
CZ302503B6 (en) 2009-12-11 2011-06-22 Contipro C A.S. Process for preparing hyaluronic acid derivative oxidized in position 6 of polysaccharide glucosamine portion to aldehyde and modification process thereof
CZ2009836A3 (en) 2009-12-11 2011-06-22 Contipro C A.S. Hyaluronic acid derivative oxidized at the 6-position of the glucosamine moiety of the polysaccharide selectively to the aldehyde, its method of preparation and its method of modification
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US8586562B2 (en) * 2010-03-12 2013-11-19 Allergan Industrie, Sas Fluid compositions for improving skin conditions
EP4062950A1 (en) 2010-03-22 2022-09-28 Allergan, Inc. Syringe comprising dermal filler for soft tissue augmentation
US8716204B2 (en) 2010-07-27 2014-05-06 Zimmer, Inc. Synthetic synovial fluid compositions and methods for making the same
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
CN102399295B (en) 2010-09-09 2013-11-06 常州百瑞吉生物医药有限公司 Low-sulfhydrylation-modification-degree biocompatible high-molecular sulfhydrylation derivatives, cross-linking material thereof, and purpose thereof
CZ302994B6 (en) 2010-12-31 2012-02-08 Cpn S.R.O. Hyaluronic fibers, method of their preparation and use
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
RU2624239C2 (en) 2011-06-03 2017-07-03 Аллерган, Инк. Dermal fillers compositions, including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9127099B2 (en) 2011-06-27 2015-09-08 Nof Corporation Polymer and method for producing same
ES2665254T3 (en) * 2011-07-12 2018-04-25 Holy Stone Healthcare Co., Ltd. Compositions comprising hyaluronic acid for treatment and prevention of mucosal related diseases
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
CZ303879B6 (en) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Derivatives based on hyaluronic acid capable of forming hydrogels, process of their preparation, hydrogels based on these derivatives, process of their preparation and use
CZ304512B6 (en) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Hyaluronic acid derivative, process for its preparation, modification process and use thereof
CZ304654B6 (en) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. C6-C18-acylated hyaluronate-based nanomicellar composition, process for preparing C6-C18-acylated hyaluronate, process for preparing nanomicellar composition and stabilized nanomicellar composition as well as use thereof
US9782345B2 (en) 2013-10-17 2017-10-10 Jade Therapeutics, Inc. Ocular composition and method
CZ2014150A3 (en) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Conjugates of hyaluronic acid oligomer or salts thereof, process of their preparation and use
EP3139903B1 (en) * 2014-05-07 2019-07-03 Croma-Pharma Gesellschaft m.b.H. Aqueous ophthalmic solution and method for treating dry eye syndrome
CZ2014451A3 (en) 2014-06-30 2016-01-13 Contipro Pharma A.S. Antitumor composition based on hyaluronic acid and inorganic nanoparticles, process of its preparation and use
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
RU2715234C2 (en) 2015-02-13 2020-02-26 Аллерган Эндюстри, Сас Implants for sculpting, augmenting or correcting facial features such as chin
CZ309295B6 (en) 2015-03-09 2022-08-10 Contipro A.S. Self-supporting, biodegradable film based on hydrophobized hyaluronic acid, method of its preparation and use
CZ2015398A3 (en) 2015-06-15 2017-02-08 Contipro A.S. A method of crosslinking polysaccharides by using photolabile protecting groups
CZ306662B6 (en) 2015-06-26 2017-04-26 Contipro A.S. Sulphated polysaccharides derivatives, the method of their preparation, the method of their modification and the use
PL3368006T3 (en) 2015-10-30 2020-06-01 Croma-Pharma Gesellschaft M.B.H. Therapeutic use of a sterile aqueous ophthalmic solution
CN108348455B (en) 2015-10-30 2021-04-09 克罗马药品股份有限公司 Therapeutic uses of sterile aqueous ophthalmic solutions
CN105537002A (en) * 2015-12-17 2016-05-04 昆明孚锐特经贸有限公司 Preparation and application of flotation separation inhibitor for mixed copper sulfide and molybdenum concentrate
ITUA20164153A1 (en) * 2016-06-07 2017-12-07 Jointherapeutics S R L Polysaccharide compositions usable in tissue repair
CZ308106B6 (en) 2016-06-27 2020-01-08 Contipro A.S. Unsaturated derivatives of polysaccharides, their preparation and their use
AR110125A1 (en) * 2016-11-07 2019-02-27 Croma Pharma Ges M B H POLYMERIC COMPOUNDS THAT RELEASE HYDROGEN SULFIDE
WO2018202783A1 (en) 2017-05-03 2018-11-08 Croma-Pharma Gmbh Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
CN112334167A (en) * 2018-06-15 2021-02-05 克罗马药品有限责任公司 Hydrogel compositions comprising crosslinked polymers
BR112020024654B1 (en) 2018-06-15 2024-02-27 Croma-Pharma Gmbh STERILE HYDROGEL COMPOSITION, APPLICATION UNIT FOR INJECTION, ITS USES, COSMETIC METHOD, SOFT TISSUE FILLING, AND IMPLANT OR DEPOSIT
CN110279610B (en) 2019-06-26 2021-06-11 常州百瑞吉生物医药有限公司 Hyaluronic acid skin protection composition and preparation method and application thereof
WO2021123247A1 (en) 2019-12-19 2021-06-24 Croma-Pharma Gmbh Thiol-modified hyaluronan and hydrogel comprising the crosslinked hyaluronan
CN113134116B (en) * 2020-01-20 2022-09-06 山东威高宏瑞医学科技有限公司 Filling composition and filling preparation for endoscopic minimally invasive surgery
WO2022147084A1 (en) * 2020-12-30 2022-07-07 Convatec Technologies Inc. Surface treatment system and method for subcutaneous device
CN119798798A (en) * 2025-01-09 2025-04-11 常州百瑞吉生物医药股份有限公司 Preparation method of aqueous solution hyaluronic acid oligosaccharide composition, composition and application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004037164A2 (en) * 2002-06-21 2004-05-06 University Of Utah Research Foundation Crosslinked compounds and methods of making and using thereof
US20070087059A1 (en) * 2005-10-17 2007-04-19 Frank Everaerts Bioactive delivery matrix compositions and methods

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US4713448A (en) * 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
JP2995090B2 (en) * 1993-03-19 1999-12-27 キユー・メド・アクチエボラーグ Compositions and methods for tissue augmentation
FR2727117A1 (en) 1994-11-18 1996-05-24 Geffard Michel USE OF POLYLYSIN CONJUGATES FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES AND DEGENERATIVE DISORDERS OF AUTOIMMUN CHARACTER
US6214331B1 (en) 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
US5785642A (en) * 1996-10-18 1998-07-28 Micro Therapeutics, Inc. Methods for treating urinary incontinence in mammals
US6630457B1 (en) * 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
WO2002068383A2 (en) * 2001-02-22 2002-09-06 Anika Therapeutics, Inc. Thiol-modified hyaluronan
US6610810B2 (en) * 2001-03-13 2003-08-26 Glyn Owen Phillips Biopolymers obtained by solid state irradiation in an unsaturated gaseous atmosphere
ITMI20011238A1 (en) * 2001-06-12 2002-12-12 Bartholdy Consultadoria E Serv POLYSACCHARIDIC POLYMERS OF NATURAL ORIGIN CHEMICALLY CONJUGATED AS PHARMACOLOGICALLY OR BIOLOGICALLY ACTIVE SUBSTANCES AND THEIR PROPERTIES
ATA13842001A (en) 2001-08-31 2002-10-15 Mucobiomer Biotechnologische F CHITOSAN-THIO-ALKYL-AMIDINE CONJUGATES AND THEIR COSMETIC AND PHARMACEUTICAL USE
GB2386900B (en) 2002-03-25 2006-11-01 Johnson & Johnson Medical Ltd Use in wound dressings of chemically modified polysaccharides
WO2004073759A1 (en) 2003-02-19 2004-09-02 Aventis Pharmaceuticals Holdings Inc. Composition and method for intradermal soft tissue augmentation
US20050282747A1 (en) * 2003-10-01 2005-12-22 The Research Foundation Of State University Of New York At Stony Brook Methods and compositions for wound healing
JP2008506750A (en) 2004-07-22 2008-03-06 ティオマトリックス・フォルシュンクス・ウント・べラートゥンクス・ゲーエムベーハー Use of compounds containing thiol groups as exhaust pump inhibitors
EP1817347B1 (en) 2004-11-24 2017-05-17 Albumedix A/S Method of cross-linking hyaluronic acid with divinylsulfone
FR2920671B1 (en) * 2007-09-07 2010-08-13 Cousin Biotech TEXTILE IMPLANT, IN PARTICULAR FOR THE REFECTION OF HERNIES

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004037164A2 (en) * 2002-06-21 2004-05-06 University Of Utah Research Foundation Crosslinked compounds and methods of making and using thereof
US20070087059A1 (en) * 2005-10-17 2007-04-19 Frank Everaerts Bioactive delivery matrix compositions and methods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BERNKOP-SCHNURCH A ET AL: "Thiolated chitosans", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 57, no. 1, 1 January 2004 (2004-01-01), pages 9 - 17, XP004518748, ISSN: 0939-6411 *
SHU XIAO ZHENG ET AL: "Disulfide Cross-Linked Hyaluronan Hydrogels", 1 January 2002, BIOMACROMOLECULES, ACS, WASHINGTON, DC, US, PAGE(S) 1304 - 1311, ISSN: 1525-7797, XP002975311 *

Also Published As

Publication number Publication date
CN101622017B (en) 2018-09-11
BRPI0722061A2 (en) 2014-04-01
DK2107913T3 (en) 2012-05-21
CY1112623T1 (en) 2016-02-10
RU2009128235A (en) 2011-01-27
BRPI0722061B1 (en) 2018-05-15
ATE545436T1 (en) 2012-03-15
EP2107913A2 (en) 2009-10-14
US9597277B2 (en) 2017-03-21
EP2107913B1 (en) 2012-02-15
AU2007336692B2 (en) 2013-12-12
CN101622017A (en) 2010-01-06
JP2010512859A (en) 2010-04-30
PT2107913E (en) 2012-05-10
WO2008077172A2 (en) 2008-07-03
US20100028399A1 (en) 2010-02-04
SI2107913T1 (en) 2012-05-31
JP5513893B2 (en) 2014-06-04
RU2432181C2 (en) 2011-10-27
CA2673323A1 (en) 2008-07-03
AU2007336692A1 (en) 2008-07-03
ES2391862T3 (en) 2012-11-30
BRPI0722061B8 (en) 2021-06-22
PL2107913T3 (en) 2012-07-31
CA2673323C (en) 2013-07-16

Similar Documents

Publication Publication Date Title
BRPI0722061A2 (en) POLYMERS USE
WO2011084521A3 (en) Therapeutic polymeric nanoparticles comprising epothilone and methods of making and using same
WO2008091835A3 (en) Implantable medical endoprostheses
WO2009099768A3 (en) Biodegradable coatings for implantable medical devices
WO2008034013A3 (en) Medical devices and methods of making the same
WO2008103278A3 (en) Coded-sequence activation of surgical implants
WO2010043980A3 (en) Surgical patch
WO2010109226A3 (en) Scaffold
EP2166060B8 (en) Stabilized aqueous polymer compositions
WO2011156590A3 (en) Non-fouling, anti-microbial, anti-thrombogenic graft compositions
WO2011117758A3 (en) Implant for tissue repair
WO2011109433A9 (en) Tissue for prosthetic implants and grafts, and methods associated therewith
WO2007117687A3 (en) Implants for the treatment of dopamine associated states
WO2008154143A3 (en) Elastomeric copolymer coatings for implantable medical devices
WO2010090767A3 (en) Enhancing biocompatibility of a medical device
WO2009150252A3 (en) Process for the preparation of depeptides from cyanophycin employing the isolated pseudomonas alcaligenes dip1 cgpase cpheal
WO2009149030A3 (en) Oral care compositions and methods
WO2008011433A3 (en) Styrenated terpene resin as well as methods of making and using the same
WO2010017466A3 (en) Phenobarbital salts; methods of making; and methods of use thereof
WO2008154132A3 (en) Implantable medical devices with elastomeric block copolymer coatings
WO2009139905A3 (en) Conjugates of a cholinesterase moiety and a polymer
WO2010001149A3 (en) Coating method for medical devices
WO2011018608A3 (en) Composition comprising phosphonic acid polymer for use as tissue engineering fibrous scaffold
WO2009158290A3 (en) Implantable medical devices fabricated from radiopaque polymers with high fracture toughness
WO2009148985A3 (en) A tissue coating for preventing undesired tissue-to-tissue adhesions

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780047621.3

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07855366

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2007336692

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2007336692

Country of ref document: AU

Date of ref document: 20071221

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2673323

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2009541680

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12520820

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2009128235

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2007855366

Country of ref document: EP

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: PI0722061

Country of ref document: BR

ENP Entry into the national phase

Ref document number: PI0722061

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20090622